Results 101 to 110 of about 3,851,688 (392)

COSMOGRAIL: the COSmological MOnitoring of GRAvItational Lenses XV. Assessing the achievability and precision of time-delay measurements

, 2015
COSMOGRAIL is a long-term photometric monitoring of gravitationally lensed QSOs aimed at implementing Refsdal's time-delay method to measure cosmological parameters, in particular H0. Given long and well sampled light curves of strongly lensed QSOs, time-
Bonvin, V., Courbin, F., Kuntzer, T., Meylan, G., Sluse, D., Tewes, M.   +5 more
core   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

Arthritis Care &Research, Accepted Article.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; NCT04179032) used three‐weight‐band ...
Hermine I. Brunner, Jordi Antón, Inmaculada Calvo‐Penadés, Richard Dimelow, Gerd Horneff, Sylvia Kamphuis, Rebecca Marino, Andre van Maurik, Kirsten Minden, Masaaki Mori, Josephine Ocran‐Appiah, Christel Wilkinson, Yuichi Yamasaki, Deepak Assudani, for the Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO) network investigators   +14 more
wiley   +1 more source

Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach

Trials, 2012
Background Maintenance of the blind-to-treatment allocation is one of the most important means of avoiding bias in randomised controlled clinical trials.
Wright Stephen, Duncombe Paul, Altman Douglas G   +2 more
doaj   +1 more source

Fexofenadine is Efficacious and Safe in Children (Aged 6-11 Years) with Seasonal Allergic Rhinitis [PDF]

, 2003
Background: This is the first prospective, randomized, doubleblind, placebo-controlled study showing statistical improvement of an H1-antihistamine in children with seasonal allergic rhinitis in all symptoms throughout the entire treatment period ...
Bachert, C, Baena-Cagnani, C, Decosta, P, Finn, A, Hedlin, G, Kowalski, M, Meltzer, E, Potter, P, Rosado-Pinto, J, Ruuth, E, Scheinmann, P, Simons, F, Wahn, U   +12 more
core  

MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY

Arthritis Care &Research, Accepted Article.
Objective Mycophenolate Mofetil (MMF) use in limited cutaneous systemic sclerosis (lcSSc) is relatively uncommon due to the lower fibrotic burden and the predominance of the vascular complications. In vitro observations and clinical data from transplanted patients suggest a protective effect of MMF on endothelial function.
Enrico De Lorenzis, Gerlando Natalello, Rossella De Angelis, Lucrezia Verardi, Dilia Giuggioli, Gianluigi Bajocchi, Lorenzo Dagna, Silvia Bellando‐Randone, Giovanni Zanframundo, Rosario Foti, Fabio Cacciapaglia, Giovanna Cuomo, Alarico Ariani, Edoardo Rosato, Gemma Lepri, Francesco Girelli, Valeria Riccieri, Elisabetta Zanatta, Ilaria Cavazzana, Francesca Ingegnoli, Maria De Santis, Giuseppe Murdaca, Giuseppina Abignano, Giorgio Pettiti, Alessandra Della Rossa, Maurizio Caminiti, Annamaria Iuliano, Giovanni Ciano, Lorenzo Beretta, Gianluca Bagnato, Ennio Lubrano, Maria Ilenia De Andres, Alessandro Giollo, Cosimo Bruni, Martina Orlandi, Marco Fornaro, Marta Saracco, Cecilia Agnes, Pier Giacomo Cerasuolo, Gabriella Alonzi, Edoardo Cipolletta, Federica Lumetti, Amelia Spinella, Luca Magnani, Corrado Campochiaro, Giacomo De Luca, Veronica Codullo, Elisa Visalli, Carlo Iandoli, Antonietta Gigante, Greta Pellegrino, Erika Pigatto, Maria‐Grazia Lazzaroni, Franco Franceschini, Elena Generali, Gianna Mennillo, Simone Barsotti, Giuseppa Pagano Mariano, Federica Furini, Licia Vultaggio, Simone Parisi, Clara Lisa Peroni, Gerolamo Bianchi, Enrico Fusaro, Gian Domenico Sebastiani, Marcello Govoni, Salvatore D'Angelo, Franco Cozzi, Fabrizio Conti, Serena Guiducci, Andrea Doria, Carlo Salvarani, Florenzo Iannone, Maria Antonietta D'Agostino, Clodoveo Ferri, Marco Matucci Cerinic, Silvia Laura Bosello, on behalf of SPRING collaborators   +77 more
wiley   +1 more source

Gender and Generosity: Does Degree of Anonymity or Group Gender Composition Matter? [PDF]

Employing a two-by-two factorial design that manipulates whether dictator groups are single or mixed-sex and whether procedures are single or double-blind, we examine gender effect in a standard dictator game.
C. Bram Cadsby, Fei Song, Maroš Servátka   +2 more
core  

Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study. [PDF]

, 2018
BackgroundIn a previous randomized, double-blind, proof-of-concept study in rapidly escalating migraine, a 3 mg dose of subcutaneous sumatriptan (DFN-11) was associated with fewer and shorter triptan sensations than a 6 mg dose.
Brand-Schieber, Elimor, Landy, Stephen, Munjal, Sagar, Rapoport, Alan M   +3 more
core   +1 more source

A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis [PDF]

, 2015
Joachim Sieper, Désirée van der Heijde, Maxime Dougados, Walter P. Maksymowych, B. B. Scott, Judith A. Boice, Yuliya Berd, G. Bergman, Sean Curtis, Anjela Tzontcheva, Susan Huyck, Hsu‐Huei Weng   +11 more
openalex   +1 more source

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

The Lancet, 2020
Ye-ming Wang, Dingyu Zhang, G. Du, R. Du, Jianping Zhao, Yang Jin, Shouzhi Fu, Ling Gao, Zhenshun Cheng, Q. Lu, Y. Hu, G. Luo, Ke Wang, Yang Lu, Huadong Li, Shuzhen Wang, Shunan Ruan, Chengqing Yang, Chunlin Mei, Yi Wang, Dan Ding, Feng Wu, Xin Tang, X. Ye, Yingchun Ye, Bing Liu, Jie Yang, Wen Yin, Aili Wang, Guohui Fan, F. Zhou, Zhibo Liu, Xiaoying Gu, Jiuyang Xu, L. Shang, Yi Zhang, Lianjun Cao, Tingting Guo, Y. Wan, H. Qin, Yushen Jiang, T. Jaki, F. Hayden, P. Horby, B. Cao, Chen Wang   +45 more
semanticscholar   +1 more source

A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease

Neurology, 2015
Objective: A randomized, placebo-controlled, double-blind, multicenter 52-week phase 2 trial of resveratrol in individuals with mild to moderate Alzheimer disease (AD) examined its safety and tolerability and effects on biomarker (plasma Aβ40 and Aβ42 ...
R. S. Turner, Ronald G. Thomas, Suzanne Craft, C. V. van Dyck, Jacobo Mintzer, B. Reynolds, J. Brewer, R. Rissman, Rema Raman, P. S. Aisen   +9 more
semanticscholar   +1 more source